Highlights of the final draft of the national policy document for science, technology and innovation in vaccine production in Iran
Introduction: Vaccination has been the most effective human intervention in alleviating human sufferings and death. Vaccine production in Iran has a long history however, in the face of a changing global landscape, it requires a new roadmap for research, development and production in the coming deca...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pasteur Institute of Iran
2015-05-01
|
| Series: | Vaccine Research |
| Subjects: | |
| Online Access: | http://vacres.pasteur.ac.ir/article-1-47-en.html |
| _version_ | 1819259812963155968 |
|---|---|
| author | P Owlia M Ghanei SM Mirafzali SD Siadat S Malekifar H Esmailzadeh H Saderi |
| author_facet | P Owlia M Ghanei SM Mirafzali SD Siadat S Malekifar H Esmailzadeh H Saderi |
| author_sort | P Owlia |
| collection | DOAJ |
| description | Introduction: Vaccination has been the most effective human intervention in alleviating human sufferings and death. Vaccine production in Iran has a long history however, in the face of a changing global landscape, it requires a new roadmap for research, development and production in the coming decades. Methods: This document was drafted based on Article A of the “Comprehensive National Scientific Roadmap”, in compliance with priorities laid out in the primary directives as well as the key concerns of the stakeholders outlined in the 20-year vision for the country, the fifth development plan, the Comprehensive National Scientific Roadmap and the Scientific map of Health System. In addition, policies of various developed and developing countries, related WHO publications and published literature on policymaking were reviewed to obtain data pertaining to topics such as the current vaccine landscape, historical and current trends, the challenges and obstacles in vaccine research, development and production as aids to decision making. Results: In the course of several sessions, the selected panel outlined the vision, mission, expected outcome, main objectives and the founding principles of the national policy document for science, technology and innovation in vaccine production in Iran. In addition, guidelines in areas of policymaking, management and laws, financial resource allocation, knowledge production, publication and knowledge sharing, human resources, expansion in product manufacturing and services, entrepreneurship and communication were outlined. Conclusion: Vaccine production in Iran is facing many challenges and to become a successful player in the global vaccine market, it requires implementation of the guidelines that have been outlined in this draft. Remaining a supplier of traditional vaccine to the domestic market, in the face of increasing competition from the emerging manufacturers, is not a viable option for this industry. |
| first_indexed | 2024-12-23T19:15:58Z |
| format | Article |
| id | doaj.art-cdb7b6c157124b23916c1e8b01c7508f |
| institution | Directory Open Access Journal |
| issn | 2383-2819 2423-4923 |
| language | English |
| last_indexed | 2024-12-23T19:15:58Z |
| publishDate | 2015-05-01 |
| publisher | Pasteur Institute of Iran |
| record_format | Article |
| series | Vaccine Research |
| spelling | doaj.art-cdb7b6c157124b23916c1e8b01c7508f2022-12-21T17:34:20ZengPasteur Institute of IranVaccine Research2383-28192423-49232015-05-012115Highlights of the final draft of the national policy document for science, technology and innovation in vaccine production in IranP Owlia0M Ghanei1SM Mirafzali2SD Siadat3S Malekifar4H Esmailzadeh5H Saderi6 Molecular Microbiology Research Center, Shahed University, Tehran, Iran, National Research Institute for Science Policy (NRISP), Tehran, Iran Pasteur Institute of Iran, Tehran, Iran, Research Center of Chemical Injuries, Baqyiatallah University of Medical Sciences, Tehran, Iran Razi Vaccine and Serum Research Institute, Tehran, Iran Pasteur Institute of Iran, Tehran, Iran Asef Think Tank, Tehran, Iran Center for Academic and Health Policy (CAHP), Tehran University of Medical Sciences, Tehran, Iran Molecular Microbiology Research Center, Shahed University, Tehran, Iran Introduction: Vaccination has been the most effective human intervention in alleviating human sufferings and death. Vaccine production in Iran has a long history however, in the face of a changing global landscape, it requires a new roadmap for research, development and production in the coming decades. Methods: This document was drafted based on Article A of the “Comprehensive National Scientific Roadmap”, in compliance with priorities laid out in the primary directives as well as the key concerns of the stakeholders outlined in the 20-year vision for the country, the fifth development plan, the Comprehensive National Scientific Roadmap and the Scientific map of Health System. In addition, policies of various developed and developing countries, related WHO publications and published literature on policymaking were reviewed to obtain data pertaining to topics such as the current vaccine landscape, historical and current trends, the challenges and obstacles in vaccine research, development and production as aids to decision making. Results: In the course of several sessions, the selected panel outlined the vision, mission, expected outcome, main objectives and the founding principles of the national policy document for science, technology and innovation in vaccine production in Iran. In addition, guidelines in areas of policymaking, management and laws, financial resource allocation, knowledge production, publication and knowledge sharing, human resources, expansion in product manufacturing and services, entrepreneurship and communication were outlined. Conclusion: Vaccine production in Iran is facing many challenges and to become a successful player in the global vaccine market, it requires implementation of the guidelines that have been outlined in this draft. Remaining a supplier of traditional vaccine to the domestic market, in the face of increasing competition from the emerging manufacturers, is not a viable option for this industry.http://vacres.pasteur.ac.ir/article-1-47-en.htmlvaccine productionpolicymakingiran |
| spellingShingle | P Owlia M Ghanei SM Mirafzali SD Siadat S Malekifar H Esmailzadeh H Saderi Highlights of the final draft of the national policy document for science, technology and innovation in vaccine production in Iran Vaccine Research vaccine production policymaking iran |
| title | Highlights of the final draft of the national policy document for science, technology and innovation in vaccine production in Iran |
| title_full | Highlights of the final draft of the national policy document for science, technology and innovation in vaccine production in Iran |
| title_fullStr | Highlights of the final draft of the national policy document for science, technology and innovation in vaccine production in Iran |
| title_full_unstemmed | Highlights of the final draft of the national policy document for science, technology and innovation in vaccine production in Iran |
| title_short | Highlights of the final draft of the national policy document for science, technology and innovation in vaccine production in Iran |
| title_sort | highlights of the final draft of the national policy document for science technology and innovation in vaccine production in iran |
| topic | vaccine production policymaking iran |
| url | http://vacres.pasteur.ac.ir/article-1-47-en.html |
| work_keys_str_mv | AT powlia highlightsofthefinaldraftofthenationalpolicydocumentforsciencetechnologyandinnovationinvaccineproductioniniran AT mghanei highlightsofthefinaldraftofthenationalpolicydocumentforsciencetechnologyandinnovationinvaccineproductioniniran AT smmirafzali highlightsofthefinaldraftofthenationalpolicydocumentforsciencetechnologyandinnovationinvaccineproductioniniran AT sdsiadat highlightsofthefinaldraftofthenationalpolicydocumentforsciencetechnologyandinnovationinvaccineproductioniniran AT smalekifar highlightsofthefinaldraftofthenationalpolicydocumentforsciencetechnologyandinnovationinvaccineproductioniniran AT hesmailzadeh highlightsofthefinaldraftofthenationalpolicydocumentforsciencetechnologyandinnovationinvaccineproductioniniran AT hsaderi highlightsofthefinaldraftofthenationalpolicydocumentforsciencetechnologyandinnovationinvaccineproductioniniran |